This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during April 2024 (epidemiological weeks 14-17). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2024 (epidemiological weeks 10-13). The data is dependent on submission of samples by clinicians and therefore may not be...
Hereditary cardiomyopathy and arrhythmia disorders are genetically heterogeneous meaning that within each category there are multiple disease genes, and many different pathogenic (disease-causing) variants with overlapping phenotypes. Determining the gene and pattern...
Influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 Influenza A and B continued to be detected at low rates during February (≤ 5%). RSV detection rates increased from 4% to 8% during the reporting period but did not reach the threshold for the start of RSV...
This report presents laboratory data for last quarter (December 2023 to February 2024) obtained from GIT molecular panels requested for patients via PathCare laboratories. Graphs include bacterial, viral and parasitic causes of diarrhoea detected on these panels for...
Prosthetic joint infection (PJI) occurs in approximately 1% of all cases of total joint arthroplasty. To mitigate this complication, pre-operative management of patient risk factors are important to improve the outcome of surgery.Pre-operative screening and the...
Respiratory viruses Human rhino/enteroviruses were the most commonly detected respiratory viruses during January 2024.Similar to December 2023, SARS-CoV-2 detection rates were in the range of 10-12%.Percentage positivity for the other respiratory viruses remained...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during 2023, with additional data from December 2023. As with the monthly respiratory pathogen reports, the data is dependent on...
Influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 • Influenza A and RSV detection rates remained low during November (≤ 2%). • The highest detection rates for influenza B percentage occurred in week 47 at 8%. • SARS-CoV-2 detection rates in weeks 44 - 47...
Influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 Influenza A and RSV detection rates were below 2% during October. Influenza B cases continued to be detected during October with positivity rates reaching 5% in weeks 42 and 43, but remained below the...